Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.
Yamaguchi Y, Takasawa K, Irabu H, Hiratoko K, Ichigi Y, Hirata K, Tamura Y, Murakoshi M, Yamashita M, Nakatani H, Shimoda M, Ishii T, Udagawa T, Shimizu M, Kanegane H, Morio T.
Yamaguchi Y, et al. Among authors: murakoshi m.
J Infect Chemother. 2022 Jun;28(6):814-818. doi: 10.1016/j.jiac.2022.01.011. Epub 2022 Jan 24.
J Infect Chemother. 2022.
PMID: 35125343
Free PMC article.